Table 2.
Demographic characteristics of incident patients with primary IgAN in 2022
| Patient characteristics | Lower bound | Upper bound | |||||
|---|---|---|---|---|---|---|---|
| Female | Male | Total | Female | Male | Total | ||
| Age (in years) | Mean ± SD | - | 34.5 ± 18.7 | 35.6 ± 17.3 | - | 42.7 ± 22.1 | 43.6 ± 22.4 |
| Median (IQR) | - | 38 (29) | 42 (27) | - | 48 (32) | 48 (36) | |
| Age groups (in years) | 0–17 (n%) | 0 (0.00) | ≤4a (≤66.7) | ≤4a (≤57.1) | ≤4a (≤100.0) | ≤4a (≤21.1) | ≤4a (≤17.4) |
| 18–29 (n, %) | 0 (0.00) | ≤4a (≤66.7) | ≤4a (≤57.1) | 0 (0.00) | 5 (26.3) | 5 (21.7) | |
| 30–39 (n, %) | 0 (0.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | ≤4a (≤21.1) | ≤4a (≤17.4) | |
| 40–49 (n, %) | ≤4a (≤100.0) | ≤4a (≤66.7) | ≤4a (≤57.1) | ≤4a (≤100.0) | ≤4a (≤21.1) | ≤4a (≤17.4) | |
| 50–59 (n, %) | 0 (0.00) | ≤4a (≤66.7) | ≤4a (≤57.1) | 0 (0.00) | 5 (26.3) | 5 (21.7) | |
| 60–69 (n, %) | 0 (0.00) | 0 (0.00 | 0 (0.00 | ≤4a (≤100.0) | ≤4a(≤21.1) | ≤4a (≤17.4) | |
| 70–79 (n, %) | 0 (0.00) | 0 (0.00 | 0 (0.00 | 0 (0.00) | 0 (0.00) | 0 (0.00) | |
| ≥80 (n, %) | 0 (0.00) | 0 (0.00 | 0 (0.00 | 0 (0.00) | ≤4a (≤21.1) | ≤4a (≤17.4) | |
| Total (n, %) | ≤4a (≤57.1) | 6 (85.7) | 7 (100.0) | ≤4 a (≤17.4) | 19 (82.6) | 23 (100.0) | |
aDue to data protection regulations patient counts ≤ 4 and corresponding percentages cannot be reported